HEALTH● LOWSep 3 · Sep 3, 2026, 2:52 PM
Pfizer, Medicus ink licensing deal worth up to $1B for antibody drug conjugate
Seeking Alpha Tech · global
Pfizer and Medicus have signed a licensing agreement valued up to $1 billion for an antibody drug conjugate.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH2h agoTexas Abortion Ban Blamed in Pregnant Woman’s Death in LawsuitNYT USHEALTH2h agoOndo Killer Drink: 49 dead, 170 affected – Health CommissionerVanguard NigeriaHEALTH2h agoThree rescued orangutans in Odisha suffering from anaemia: OfficialsThe HinduHEALTH2h agoSusie Wiles: ‘I am cancer free’The Hill